NASHUA, N.H., April 27, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended March 31, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on Wednesday, May 11.
Wednesday, May 11th at 4:30 PM ET | |
Domestic: | 888-506-0062 |
International: | 973-528-0011 |
Conference ID: | 728427 |
Webcast: | https://www.webcaster4.com/Webcast/Page/2879/45416 |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Inquiries:
iCAD Investor Relations
ir@icadmed.com
GALWAY, Ireland, June 11, 2025 /PRNewswire/ -- TE Connectivity plc (NYSE: TEL) announced today that…
BROOKFIELD, Wis., June 11, 2025 /PRNewswire/ -- SRM Equity Partners ("SRM"), an operationally focused private…
MSD Solutions Lab programs unite academic researchers and industry partners to drive innovation WASHINGTON, June…
Darby 3.0 automates patient intake workflows from fax to EMR, helping HME providers scale without…
Empowering researchers at every level to test hypotheses, validate findings, and collaborate to advance science…
— One of 65 startups chosen from nearly 1,500 global applicants — — Selected to…